The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Open accessAbstract
The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals 1–3 . Despite the reduced protection from infection, individuals who received three doses of an mRNA vaccine were highly protected from more serious consequences of infection 4 . Here we examine the memory B cell repertoire in a longitudinal cohort of individuals receiving three mRNA vaccine doses 5,6 . We find that the third dose is accompanied by an increase in, and evolution of, receptor-binding domain (RBD)-specific memory B cells. The increase is due to expansion of memory B cell clones that were present after the second dose as well as the emergence of new clones. The antibodies encoded by these cells showed significantly increased potency and breadth when compared with antibodies obtained after the second dose. Notably, the increase in potency was especially evident among newly developing clones of memory cells, which differed from persisting clones in targeting more conserved regions of the RBD. Overall, more than 50% of the analysed neutralizing antibodies in the memory compartment after the third mRNA vaccine dose neutralized the Omicron variant. Thus, individuals receiving three doses of an mRNA vaccine have a diverse memory B cell repertoire that can respond rapidly and produce antibodies capable of clearing even diversified variants such as Omicron. These data help to explain why a third dose of a vaccine that was not specifically designed to protect against variants is effective against variant-induced serious disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A booster serves as a re-exposure to the virus, which creates new antibodies as well as additional and improved memory B-cells responses to fight off future infections.”
From Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024 (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has even been found that booster exposure also improves the ability of the memory B-cells to recognise unknown variants such as the Omicron strain [18, 20].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Sievers, F., Wilm, A., Dineen, D., Gibson, T., Karplus, K., Li, W.-Z., Lopez, R., McWilliam, H., Remmert, M., Söding, J., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.75 · Cited by 15,576
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Self-citationA serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Self-citationREGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
Weinreich, D. M., Sivapalasingam, S., Norton, T., Ali, S., Gao, H., Bhore, R., Musser, B. J., Soo, Y., Rofail, D., Im, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035002 · Cited by 1,642
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M. A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2852-1 · Cited by 1,599
Self-citationConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures
Landau, M., Mayrose, I., Rosenberg, Y., Glaser, F., Martz, E., Pupko, T., & Ben‐Tal, N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki370 · Cited by 1,379
Cited by
Sorted by citations
Items 201–298 of 298
Fu, J. Y. L., Omar, S. F. S., Rajasuriar, R., Kukreja, A., Basri, S., Kamarulzaman, A., Tan, C. S., Said, A., Su’ut, L., Lim, S. K., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127657 · Cited by 3
Affinity maturation and light-chain-mediated paratope diversification anticipates viral evolution
Dingus, J. G., Yoo, D. K., Kumar, S., Wang, Y., Kibria, M. G., Saghaei, S., Allahyari, Z., Chen, J. W., Caputo, N., Hwang, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116800 · Cited by 3
Hisham, A. A. M., Yassim, A. S. M., Suppıan, R., Azlan, M., Asri, A. A. M., Idris, N. S., Muhamad, R., & Norazmi, M. N. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126471 · Cited by 3
Knox, J. J., Lee, I., Blumberg, E. A., Rosenfeld, A. M., Meng, W., Liu, F., Kearns, C., O’Doherty, U., Shaked, A. A., Olthoff, K. M., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf250 · Cited by 3
Wang, Q., Wang, S., Liu, Y., Wang, S., Peng, H., Hao, Y., Hong, K., Li, D., & Shao, Y. (2023) · Pathogens · doi:10.3390/pathogens12050655 · Cited by 3
Berry, C., Pavot, V., Anosova, N. G., Kishko, M., Li, L., Tibbitts, T., Raillard, A., Gautheron, S., Cummings, S., Bangari, D. S., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00302-z · Cited by 4
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster
Nielsen, S. S. F., Barnkob, N. M., Hansen, R. W., Bansia, H., Vestergaard, M., Rothemejer, F. H., Worsaae, A., Brown, D., Pedersen, M. L., Rahimic, A. H. F., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291131 · Cited by 3
Li, Y., Mo, J., Liu, J., Liang, Y., Deng, C., Huang, Z., Jiang, J., Liu, M., Liu, X., Shang, L., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108086 · Cited by 4
Babu, T. M., Shen, X., McClelland, R. S., Wang, Z., Selke, S., Wilkens, C., Hauge, K. A., McClurkan, C. L., Goecker, E. A., Laing, K. J., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad673 · Cited by 3
Self-citationPriddey, A. J., Chen-Xu, M., Cooper, D. J., MacMillan, S., Meisl, G., Xu, C. K., Hosmillo, M. D. T., Goodfellow, I., Kollyfas, R., Döffinger, R., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1296148 · Cited by 4
Li, X., Zeng, F., Yue, R., Ma, D., Meng, Z., Li, Q., Zhang, Z., Zhang, H., Liao, Y., Liao, Y., et al. (2024) · Vaccines · doi:10.3390/vaccines12020120 · Cited by 3
Systems biology of B cells in COVID-19
Woodruff, M. C., Faliti, C. E., & Sanz, I. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101875 · Cited by 3
Chen, X., Mohapatra, A., Nguyen, H. T. V., Schimanski, L. M., Tan, T. K., Rijal, P., Chen, C., Cheng, S., Lee, W.-H., Chou, Y., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012246 · Cited by 3
Kuijper, L. H., Kreher, C., Elias, G., Claireaux, M. A. F., Kerster, G., Bos, A. V., Duurland, M. C., Konijn, V. A. L., Paul, A., de Jong, N., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1505719 · Cited by 6
Estephan, L., Liu, L. T.-C., Lien, C.-E., Smith, E. R., Gurwith, M., & Chen, R. T. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.083 · Cited by 3
Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2Preprint
Zhou, R., Liu, N., Li, X., Peng, Q., Yiu, C.-K., Huang, H., Yang, D., Du, Z., Kwok, H., Au, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.09.491254 · Cited by 3
Durable reprogramming of neutralising antibody responses following breakthrough Omicron infectionPreprint
Lee, W. S., Tan, H., Reynaldi, A., Esterbauer, R., Koutsakos, M., Nguyen, J. T., Amarasena, T. H., Kent, H. E., Aggarwal, A., Turville, S. G., et al. (2023) · medRxiv · doi:10.1101/2023.02.19.23286159 · Cited by 3
Keijser, J. B. D., Stalman, E. W., Wieske, L., Steenhuis, M., van Dam, K. P. J., Kummer, L. Y. L., van Kempen, Z. L. E., Killestein, J., Volkers, A., Tas, S. W., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105620 · Cited by 2
Kartal, O., Hoeggerl, A. D., Lauth, W., Weidner, L., Badstuber, N., Grabmer, C., Jungbauer, C., Nunhofer, V., Neureiter, H., Held, N., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16020195 · Cited by 2
Optimizing mouse models for mRNA vaccines: addressing dose translation challenges
Chang, Z. W., Tan, Y. J., Liao, Y., Goh, Y. S., Kabir, S. R., Wang, Y., Hor, P. X., Loh, C. Y., Huang, Y., Wang, B., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47820-z · Cited by 2
Yang, L., Xu, L., Guo, Q., Deng, B., Hong, Y., Wang, L., Wang, Y., Jiang, D., & Ren, H. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.78766 · Cited by 3
Shen, X., Hao, Y., Wang, S., Li, D., Ren, L., Zhu, M., Wang, S., Li, J., Tang, W., Fu, Y., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.09.030 · Cited by 2
Ozawa, T., Ikeda, Y., Chen, L., Suzuki, R., Hoshino, A., Noguchi, A., Kita, S., Anraku, Y., Igarashi, E., Saga, Y., et al. (2024) · Structure · doi:10.1016/j.str.2023.12.013 · Cited by 2
Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates
Yi, D., Zhang, Y., Wang, J., Liu, Q., Ma, L., Li, Q., Guo, S., Zheng, R., Li, X., Li, X., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.12.003 · Cited by 2
Wang, M., Liu, C., Fan, Q., Sun, Y., Tang, S., Guo, H., Zhou, B., Wang, H., Ge, X., Zhang, Z., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkae056 · Cited by 2
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine
Pietà, A. D., Genova, B., Penna, A., Sinigaglia, A., Vogiatzis, S., Barzon, L., Pagliari, M., Bonfante, F., Torrigiani, F., Sofia, T., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113674 · Cited by 2
Deng, Y., Tang, M., Ross, T. M., Schmidt, A. G., Chakraborty, A. K., & Lingwood, D. (2025) · eLife · doi:10.7554/elife.107042 · Cited by 4
Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2
Wang, B., Xu, H., Liang, Z., Zhao, T.-N., Zhang, X., Peng, T., Wang, Y., & Su, X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.120 · Cited by 2
Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanismPreprint
Luo, S., Zhang, J., Kreutzberger, A. J. B., Eaton, A., Edwards, R. J., Jing, C., Dai, H., Sempowski, G. D., Cronin, K. D., Parks, R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.26.497634 · Cited by 2
Relationship between B-Cell Populations, Development and Function of B-Cell Subsets
Mortari, E. P., & Carsetti, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95895-0.00022-2 · Cited by 1
Talreja, J., Peng, C., Zhang, K., & Samavati, L. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0428oc · Cited by 1
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US
Chen, N. F. G., Pham, K., Chaguza, C., Lopes, R., Klaassen, F., Kalinich, C. C., Initiative, Y. S.-C. G. S., Kerantzas, N., Pandya, S., Ferguson, D., et al. (2025) · Viruses · doi:10.3390/v17071020 · Cited by 1
Fedele, G., Schiavoni, I., Trentini, F., Leone, P., Olivetta, E., Fiore, S., Martino, A. D., Abrignani, S., Bandera, A., Clerici, P., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127524 · Cited by 1
Wen, G., Wang, Y., Wang, M.-M., Wang, W., Wang, S., Wang, Z., Tang, Z., Luo, Z.-Y., Chen, Z., Chen, J., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01357-5 · Cited by 1
Self-citationIslas, C. P. D., Magaret, C. A., Molitor, C., Serebryannyy, L., Narpala, S., Castro, M., Posavad, C. M., Roberts, P. C., Lyke, K. E., Atmar, R. L., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127738 · Cited by 1
Mingos, A., Pechlivanis, N., Karakatsoulis, G., Anastasiadou, A., Gkoliou, G., Vastarouchas, N., Siorenta, A., Marinaki, S., Tsoutsoura, P., Papamentzelopoulou, M., et al. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag004 · Cited by 1
Lima, N. S., McCormick, L., Li, S., Wake, C., Subramanian, R., Spangler, A., Pinto, Y., Catalano, W. L., Henry, A. R., Laboune, F., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aeb9837 · Cited by 1
den Hartog, Y., van Sleen, Y., Gommers, L., Zaeck, L. M., Geers, D., Messchendorp, A. L., Sanders, J., Baan, C. C., van Baarle, D., de Vries, R. D., et al. (2026) · npj Viruses · doi:10.1038/s44298-026-00178-5 · Cited by 1
HKU1 immune imprinting is associated with post-COVID symptoms after SARS-CoV-2 infection
Majdoubi, A., Michalski, C., Watts, A. W., Dang, X., Golzan, S. A., Abu-Raya, B., Li, S., Shew, J., Reicherz, F., Mâsse, L. C., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115175 · Cited by 1
Chakraborty, A. K., Jayaraman, A., & Newton, D. (2026) · PRX Life · doi:10.1103/znt6-6n38 · Cited by 1
Mapping immune imprinting zones enables predictive vaccination optimization
Yang, W., Jin, K., Li, W., Ding, Z., Yu, H., Zhou, Z., Su, W., Zhu, X. L., Ma, X., Wan, N., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117271 · Cited by 1
Koirala, A., Prasad, S. A., Tjiam, M. C., Britton, P. N., Tedja, C., Downes, M., Skowno, J., Wadia, U. D., Blyth, C. C., Crawford, N. W., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128705 · Cited by 1
SARS-CoV-2 infection and vaccination elicit distinct pharyngeal mucosal B cell responses in children
Xu, Q., Shi, L., Wang, L., Cheung, F., Kotekar, A., Koroleva, G., Rice, E., Apps, R., Lack, J., Martens, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72996-3 · Cited by 1
Kit, Y. Y., Starykovych, M. O., Manko, N. O., Orfin, А. Y., Alexanyan, T., Bozhko, L., Turchyna, T., Kit, O. Y., Krishnankutty, R., Anand, A., et al. (2023) · Journal of Immunological Methods · doi:10.1016/j.jim.2023.113437 · Cited by 1
Herwig, S., Adler, J. M., Vladimirova, D., Trimpert, J., Sehouli, J., & Cichon, G. (2024) · Vaccines · doi:10.3390/vaccines12030248 · Cited by 1
Huang, M., Cui, T., Liu, S., Su, X., Wang, Y., Wang, J., Zhong, J., Cao, J., Mei, X., Li, K., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29544 · Cited by 1
Self-citationStalman, E. W., Wieske, L., Keijser, J. B. D., van Dam, K. P. J., Kummer, L. Y. L., Wilbrink, M. F., van Kempen, Z. L. E., Killestein, J., Volkers, A., Tas, S. W., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.04.031 · Cited by 1
Wall, N. A., Lamerton, R. E., Ashford, F. B., Pérez-Toledo, M., Jasiulewicz, A., Banham, G. D., Newby, M. L., Faustini, S. E., Richter, A. G., Selvaskandan, H., et al. (2024) · Vaccines · doi:10.3390/vaccines13010007 · Cited by 1
Lu, B., Chaudhary, O., Banoth, B., Nadkarni, J., Zong, W., Mausser, E., Danz, H., Motwani, M., Ruiz, S., Zhang, D., et al. (2025) · Vaccines · doi:10.3390/vaccines13030263 · Cited by 1
Berry, C., Pavot, V., Anosova, N. G., Kishko, M., Huang, D., Tibbitts, T., Raillard, A., Gautheron, S., Cummings, S., Bangari, D. S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1928234/v1 · Cited by 1
Chernyshev, M., Sakharkar, M., Connor, R. I., Dugan, H. L., Sheward, D. J., Rappazzo, C. G., Stålmarck, A., Forsell, M. N. E., Wright, P. F., Corcoran, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2231608/v1 · Cited by 1
Asokan, M., Joan, R. F., Babji, S., Dayma, G., Nitheesh, P., Subrahmanyam, V., Pandey, A., Malagi, G., Arya, P., Mahajan, V., et al. (2023) · medRxiv · doi:10.1101/2023.01.03.22284082 · Cited by 1
Seow, J., Shalim, Z. A., Graham, C., Kimuda, S., Pillai, A., Lechmere, T., Kurshan, A., Khimji, A. M., Snell, L., Nebbia, G., et al. (2023) · bioRxiv · doi:10.1101/2023.03.30.534872 · Cited by 1
Humoral immune response to omicron infection in long-term Wuhan-Hu-1-imprinted populationPreprint
Lü, Y., Zhu, Y., Zheng, Y., Tang, L., Chen, H., Zhou, C.-L., Luo, J., Yang, X., Yu, L., Hu, Q., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3024491/v1 · Cited by 1
Wall, N., Lamerton, R. E., Ashford, F. B., Pérez-Toledo, M., Jasiulewicz, A., Banham, G. D., Newby, M. L., Faustini, S. E., Richter, A. G., Selvaskandan, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.14.575569 · Cited by 1
Wood, N., Wadia, U. D., Richmond, P., Argent, C., Marshall, H. S., Sandgren, K. J., Tungatt, K., Gomes, G. M. C., Asquith, W., Taylor, J., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4764794 · Cited by 1
Fujitani, M., Lu, X., Shinnakasu, R., Inoue, T., Kidani, Y., Seki, N. M., Ishida, S., Mitsuki, S., Ishihara, T., Aoki, M., et al. (2024) · medRxiv · doi:10.1101/2024.10.01.24314659 · Cited by 1
Antibody responses to AZD1222 vaccination in West AfricaPreprint
Abdullahi, A., Oladele, D. A., Kemp, S. A., James, A. B., Salako, A. O., Ige, F. A., Fink, D., Onwuamah, C. K., Osuolale, Q., Abubakar, R., et al. (2022) · medRxiv · doi:10.1101/2022.05.04.22274668
Three-Dose Vaccination-Induced Immune Responses Protect Against SARS-CoV-2 Omicron BA.2Preprint
Zhou, R., Liu, N., Li, X., Peng, Q., Yiu, C.-K., Huang, H., Yang, D., Du, Z., Kwok, H., Au, K., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4123263
Mise‐Omata, S., Ikeda, M., Takeshita, M., Uwamino, Y., Wakui, M., Arai, T., Yoshifuji, A., Murano, K., Siomi, H., Nakagawara, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.31.500554
Impfung gegen coronavirus disease 2019 (COVID-19)
Weinberger, B. (2022) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-022-02102-x
Sant, A. J., & Wilson, P. C. (2022) · Nature Immunology · doi:10.1038/s41590-022-01320-0
Mortari, E. P., Pulvirenti, F., Marcellini, V., Terreri, S., Salinas, A. F., Ferrari, S., Napoli, G. D., Guadagnolo, D., Sculco, E., Albano, C., et al. (2022) · medRxiv · doi:10.1101/2022.12.24.22283775
Wagh, K., Shen, X., Theiler, J. P., Girard, B., Marshall, J.-C. A., Montefiori, D. C., & Korber, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.13.553144
Yasugi, M., Nakagama, Y., Kaku, N., Nitahara, Y., Hatanaka, N., Yamasaki, S., & Kido, Y. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.08.076
Thole, L. M. L., Toth, L., Proß, V., Siegle, J., Stahl, C., Hermsdorf, G., Knabe, A., Winkler, A., Schrezenmeier, E. V., Ludwig, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1239519
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
Ziegler, L., Klemis, V., Schmidt, T., Schneitler, S., Baum, C., Neumann, J., Becker, S. L., Gärtner, B. C., Sester, U., & Sester, M. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104853
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
Iro, M. A., & Buckland, M. S. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104852
The Covid-19 and TB Syndemic: Differences and Similarities
Kaufmann, S. H. E., Sher, A., Sigal, A., & Sawitzki, B. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-4116-6
Chen, N. F. G., Pham, K., Chaguza, C., Lopes, R., Klaassen, F., Weinberger, D. M., Pitzer, V. E., Warren, J. L., Grubaugh, N. D., & Hahn, A. M. (2024) · medRxiv · doi:10.1101/2024.01.03.24300790
Haralambieva, I. H., Monroe, J. M., Ovsyannikova, I. G., Warner, N. D., Grill, D. E., Poland, G. A., & Kennedy, R. B. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.01.032
Dinç, H. Ö., Can, G., Budak, B., Daşdemir, F. O., Keskin, E., Uysal, H. K., Aydoğan, O., Balkan, İ. İ., Karaali, R., Ergin, S., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4777941
Dinç, H. Ö., Can, G., Budak, B., Daşdemir, F. O., Keskin, E., Uysal, H. K., Aydoğan, O., Balkan, İ. İ., Karaali, R., Ergin, S., et al. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116425
Mondi, A., Mastrorosa, I., Navarra, A., Cimaglia, C., Pinnetti, C., Mazzotta, V., Agresta, A., Corpolongo, A., Zolezzi, A., Moghazi, S. A., et al. (2024) · Vaccines · doi:10.3390/vaccines12091018 · Cited by 1
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients
Ammitzbøll, C. G., Thomsen, M. K., Erikstrup, C., & Troldborg, A. (2024) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2024.09.006
Altered spike dynamics drives immune evasion of SARS-CoV-2Preprint
Saksela, K., Uğurlu, H., Salminen, P., Yuan, M., Fagerlund, R., Mäkelä, A. R., Žusinaite, E., Kesti, T., Rissanen, I., Merits, A., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5310668/v1
Kim, D. R., Park, B. K., Baek, J. Y., Shin, A., Lee, J. W., Ju, H. Y., Cho, H. W., Yoo, K. H., Sung, K. W., Jeong, C.-H., et al. (2024) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e52
Pfister, H., Uhlig, C., Mayer, Z., Polatoglou, E., Randeu, H., Burglechner-Praun, S., Berchtold, T., Sernetz, S., Heitzer, F., Strötges-Achatz, A., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5678273/v1
Rinchai, D., Deola, S., Kabeer, B. S. A., Gentilcore, G., Toufiq, M., Mathew, L. S., Liu, L., Vempalli, F. R., Mubarak, G., Lorenz, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.09.631990
Barnkob, M. B., Larsen, E. S., Nilsson, A. C., Usheva, Z., Stougaard, C. L., Bang, N., Christensen, E. B., Rasmussen, K. M., Bang, L. L., Tornby, D. R., et al. (2025) · medRxiv · doi:10.1101/2025.05.20.25327919
Kittikraisak, W., Leepiyasakulchai, C., Saelee, C., Tanathitikorn, C., Suttha, P., Punjasamanvong, S., Piyaraj, P., Wongrapee, T., Yoocharoen, P., Chottanapund, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-10400-8
Pfister, H., Uhlig, C., Mayer, Z., Polatoglou, E., Randeu, H., Burglechner-Praun, S., Berchtold, T., Sernetz, S., Heitzer, F., Strötges-Achatz, A., et al. (2025) · Vaccines · doi:10.3390/vaccines13080867
Kubo, R., Yoshikawa, R., Fujii, Y., Kawasaki, T., Takazono, T., Izumikawa, K., Ariyoshi, K., Mukae, H., & Yasuda, J. (2025) · Tropical Medicine and Health · doi:10.1186/s41182-025-00807-4
Khan, R. A., Chen, J., Donius, L. R., Reinherz, E. L., & Kim, M. (2026) · npj Vaccines · doi:10.1038/s41541-026-01371-6
Song, Y., Wu, F., Wang, R., Zheng, W., He, B., Yan, Q., Huang, X., Li, Y., Chen, S., Yuan, Q., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700456
Kiamba, E. W., Ajiboye, D. O., Bashorun, A. O., Jallow, M. N., Drammeh, L., Bah, S., Jobarteh, T., Kanu, F. J., Jawla, O., Jobarteh, L., et al. (2026) · npj Vaccines · doi:10.1038/s41541-026-01408-w
Étude de la réponse humorale lors de l'infection par le SARS-CoV-2
Marot, S. (2023) · theses.fr (ABES) · doi:10.70675/7d41e61azd818z408dzb17cz1c0cf0738b83
Qiu, K., Zhu, Q., Cai, D., Deng, Z., Zha, G., Xue, Y., Peng, M., Hu, P., & Ren, H. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102222
Rodrigues, D., Araujo, B., Pestana, J., da Costa, L. C., Andrade, M. V., de Freitas, L., Nery, B., Bozza, V. B. T., Conde, L., Raposo, L., et al. (2026) · medRxiv · doi:10.64898/2026.04.30.26352163
Yao, L., Megyesi, Z., Lehmann, P. V., & Kirchenbaum, G. A. (2026) · Vaccines · doi:10.3390/vaccines14070604
Tonouchi, K., Finney, J., San, E. J., Itallie, E. S. V., Beem, J. S. M., Liao, D., Liang, X., Yuan, L., Szafranski, S. E., Kuraoka, M., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7321279
Suryadevara, N., Zost, S. J., Powers, J. M., Dadonaite, B., Gilchuk, P., Binshtein, E., Scheaffer, S. M., Leist, S. R., Myers, L., Ravera, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.15.745004
Zhang, Q., Chen, P., Guo, F., Zhou, R., Guo, R., Ge, X., Yang, Q., Xie, X., Xia, W., Fan, J., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.08.009
Desai, M., Cardona, J., Khetan, S. K., Mehta, S., Kapoor, A., Okparavero, A., Lin, Z., & Priddy, F. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129068
Early functional maturation of anti-Spike antibodies predicts efficient SARS-CoV-2 RNA clearance
Rodrigues, D., de Araujo, B. G., Pestana, J., de Freitas, L., Ramos, B. N., da Costa, L. C., Andrade, M. V., Raposo, L. M., Bozza, V. B. T., Conde, L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1948045
Spatial confinement promotes germinal center diversity and tempers immunodominance
Chen, K. Y., Hu, K. H., Kirthivasan, N., Rao, A., Schwan, N., An, J., Xu, Y., Peng, V., Magnen, M., Huang, S., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02698-x
Metadata
- Authors
- Muecksch, F., Wang, Z., Cho, A., Gaebler, C., Ben Tanfous, T., DaSilva, J., Bednarski, E., Ramos, V., Zong, S., Johnson, B., Raspe, R., Schaefer-Babajew, D., Shimeliovich, I., Daga, M., Yao, K.-H., Schmidt, F., Millard, K. G., Turroja, M., Jankovic, M., Oliveira, T. Y., Gazumyan, A., Caskey, M., Hatziioannou, T., Bieniasz, P. D., & Nussenzweig, M. C.
- Affiliations
- Rockefeller University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Bieniasz, Paul D.
- Nussenzweig, Michel C.
- ORCID
- Muecksch, Frauke
- Wang, Zijun
- Cho, Alice
- Gaebler, Christian
- DaSilva, Justin
- Bednarski, Eva
- Ramos, Victor
- Zong, Shuai
- Johnson, Brianna
- Raspe, Raphael
- Schaefer-Babajew, Dennis
- Shimeliovich, Irina
- Daga, Mridushi
- Yao, Kai-Hui
- Schmidt, Fabian
- Millard, Katrina G.
- Turroja, Martina
- Oliveira, Thiago Y.
- Gazumyan, Anna
- Caskey, Marina
- Hatziioannou, Theodora
- Bieniasz, Paul D.
- Nussenzweig, Michel C.
- Venue
- Nature
- Published
- 2022-04-21
- Volume
- 607
- Issue
- 7917
- Pages
- 128-134
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC9259484
- OpenAlex
- W4224232962
- Cited by
- 297
- References
- 45
- Citations by year
- 2026: 27 · 2025: 39 · 2024: 65 · 2023: 86 · 2022: 80
- FWCI
- 33.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (2U19AI111825, P01-AI138398-S1, UL1 TR001866, R01AI78788, R37-AI64003)
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, Omicron variant, mRNA vaccines, booster vaccination, memory B cells, receptor binding domain, neutralizing antibodies, antibody potency, antibody breadth, B cell clones, longitudinal cohort
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, Memory B Cells, Antibodies, Viral, Humans, Immunization, Secondary, RNA, Messenger, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
